Ceftriaxone (Rocephin) for Gonorrhea: Dosage and Expected Symptom Relief

Recommended Regimen (CDC 2021+)

  • Uncomplicated urogenital/rectal/pharyngeal gonorrhea: Ceftriaxone 500 mg IM single dose (for persons <150 kg; 1 g if ≥150 kg).
  • Note: The older 125 mg dose is no longer recommended due to rising antimicrobial resistance.
  • If chlamydia co-infection not excluded, add doxycycline 100 mg PO BID × 7 days.

Symptom Resolution Timeline

  • Urethral discharge/dysuria: typically improve within 24–72 hours.
  • Rectal/pharyngeal symptoms: similar timeline.
  • Persistent symptoms >7 days → re-evaluate for resistance, reinfection, or alternative diagnosis.

Follow-Up

  • Test-of-cure (NAAT) at 7–14 days if treated with non-recommended regimen, pregnant, or pharyngeal infection.
  • Re-screen at 3 months (high reinfection rate).
  • Partner notification and treatment essential.

Always verify current local guidelines as resistance patterns and recommendations evolve.

Gonorrhea - Related Articles